John L. Leguyader

Array ( [id] => 4006532 [patent_doc_number] => 05962235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Human and rat gamma glutamyl hydrolase antibodies' [patent_app_type] => 1 [patent_app_number] => 9/128722 [patent_app_country] => US [patent_app_date] => 1998-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14586 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962235.pdf [firstpage_image] =>[orig_patent_app_number] => 128722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106872 [patent_doc_number] => 06051758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Recombinant sweet protein mabinlin' [patent_app_type] => 1 [patent_app_number] => 9/081691 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10423 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051758.pdf [firstpage_image] =>[orig_patent_app_number] => 081691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176818 [patent_doc_number] => 06037156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'DNA molecules and vectors encoding clavulanic acid biosynthesis enzymes' [patent_app_type] => 1 [patent_app_number] => 9/036738 [patent_app_country] => US [patent_app_date] => 1998-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4644 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037156.pdf [firstpage_image] =>[orig_patent_app_number] => 036738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045588 [patent_doc_number] => 05968733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Mycobacteriophages and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/014560 [patent_app_country] => US [patent_app_date] => 1998-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 26 [patent_no_of_words] => 20477 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968733.pdf [firstpage_image] =>[orig_patent_app_number] => 014560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4214510 [patent_doc_number] => 06087172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Ribozymes targeted to human IL-15 mRNA' [patent_app_type] => 1 [patent_app_number] => 8/962503 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9201 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087172.pdf [firstpage_image] =>[orig_patent_app_number] => 962503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837952 [patent_doc_number] => 05846949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Method for eliciting an immune response using a gene expression system that co-delivers an RNA polymerase with DNA' [patent_app_type] => 1 [patent_app_number] => 8/943599 [patent_app_country] => US [patent_app_date] => 1997-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 10321 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846949.pdf [firstpage_image] =>[orig_patent_app_number] => 943599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027061 [patent_doc_number] => 05902728 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Diazodenitrification in manufacture of recombinant bacterial biosensors' [patent_app_type] => 1 [patent_app_number] => 8/933561 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4547 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902728.pdf [firstpage_image] =>[orig_patent_app_number] => 933561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934229 [patent_doc_number] => 05972704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'HIV nef targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/910408 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 15 [patent_no_of_words] => 22901 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972704.pdf [firstpage_image] =>[orig_patent_app_number] => 910408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992832 [patent_doc_number] => 05985661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Anti-HIV ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/909768 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 4771 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985661.pdf [firstpage_image] =>[orig_patent_app_number] => 909768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016400 [patent_doc_number] => 05880277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Ribozyme cleavage of 5.alpha.-reductase mRNA' [patent_app_type] => 1 [patent_app_number] => 8/895235 [patent_app_country] => US [patent_app_date] => 1997-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4019 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880277.pdf [firstpage_image] =>[orig_patent_app_number] => 895235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989669 [patent_doc_number] => 05891687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Positive selection vector based on the caps gene, pCAPs vector and its use' [patent_app_type] => 1 [patent_app_number] => 8/892272 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4473 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891687.pdf [firstpage_image] =>[orig_patent_app_number] => 892272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4026987 [patent_doc_number] => 05902724 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Signal amplification method' [patent_app_type] => 1 [patent_app_number] => 8/893535 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9937 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902724.pdf [firstpage_image] =>[orig_patent_app_number] => 893535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3940802 [patent_doc_number] => 05989908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Modulation of drug and radiation resistant genes' [patent_app_type] => 1 [patent_app_number] => 8/793878 [patent_app_country] => US [patent_app_date] => 1997-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 6527 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989908.pdf [firstpage_image] =>[orig_patent_app_number] => 793878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047163 [patent_doc_number] => 05968825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene' [patent_app_type] => 1 [patent_app_number] => 8/859389 [patent_app_country] => US [patent_app_date] => 1997-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 3935 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968825.pdf [firstpage_image] =>[orig_patent_app_number] => 859389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979664 [patent_doc_number] => 05948761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Recombinant canine brain natriuretic peptide' [patent_app_type] => 1 [patent_app_number] => 8/850910 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 8 [patent_no_of_words] => 17143 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948761.pdf [firstpage_image] =>[orig_patent_app_number] => 850910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040886 [patent_doc_number] => 05874244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Human NADH dehydrogenase subunits and DNA thereof' [patent_app_type] => 1 [patent_app_number] => 8/845256 [patent_app_country] => US [patent_app_date] => 1997-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18635 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874244.pdf [firstpage_image] =>[orig_patent_app_number] => 845256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743865 [patent_doc_number] => 05801154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Antisense oligonucleotide modulation of multidrug resistance-associated protein' [patent_app_type] => 1 [patent_app_number] => 8/835770 [patent_app_country] => US [patent_app_date] => 1997-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11501 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801154.pdf [firstpage_image] =>[orig_patent_app_number] => 835770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3954221 [patent_doc_number] => 05935830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'Targeted mutagenesis in living cells using modified oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/827116 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11224 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935830.pdf [firstpage_image] =>[orig_patent_app_number] => 827116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245064 [patent_doc_number] => 06136601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Targeted mutagenesis in living cells using modified oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/827117 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11399 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136601.pdf [firstpage_image] =>[orig_patent_app_number] => 827117 [rel_patent_id] =>[rel_patent_doc_number] =>)